跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial
Approved
STANDARD
HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b7ca4106e2fdd660
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b7ca4106e2fdd660
Product Name
HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial
Artg Id
211468
Artg Name
HOSPIRA LEVETIRACETAM CONCENTRATE FOR IV INFUSION levetiracetam 500 mg/5 mL concentrate for infusion vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2014-07-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/02380c5b03645d8a2b379c6687e22628.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/dfa04533e4efabc4cbd4a5f67ba66c33.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b7ca4106e2fdd660
Type
Standard
Back to TGA Approvals